Colleton Medical Center | |
501 Robertson Boulevard, Walterboro, South Carolina 29488 | |
(843) 782-2000 | |
Name | Colleton Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 501 Robertson Boulevard, Walterboro, South Carolina |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 420030 |
NPI Number | 1376597997 |
Organization Name | WALTERBORO COMMUNITY HOSPITAL, INC. |
Address | 501 Robertson Blvd, Walterboro, SC 29488 |
Hospital Type | General Acute Care Hospital |
Phone Number | 843-782-2000 |
News Archive
Bacteria and other microorganisms in the digestive tract are linked with dozens of health conditions including high blood pressure, high blood lipids, and body mass index (BMI) according to research presented today at ESC Congress 2020.
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.
A major cross institutional research collaboration aimed at reducing the number of patients harmed in Australia has received $8.4 million in funding in the latest round of National Health and Medical Research Council (NHMRC) program grants.
› Verified 6 days ago
NPI Number | 1487608436 |
Organization Name | WALTERBORO COMMUNITY HOSPITAL, INC. |
Address | 501 Robertson Blvd, Walterboro, SC 29488 |
Hospital Type | General Acute Care Hospital |
Phone Number | 843-782-2000 |
News Archive
Bacteria and other microorganisms in the digestive tract are linked with dozens of health conditions including high blood pressure, high blood lipids, and body mass index (BMI) according to research presented today at ESC Congress 2020.
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.
A major cross institutional research collaboration aimed at reducing the number of patients harmed in Australia has received $8.4 million in funding in the latest round of National Health and Medical Research Council (NHMRC) program grants.
› Verified 6 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Bacteria and other microorganisms in the digestive tract are linked with dozens of health conditions including high blood pressure, high blood lipids, and body mass index (BMI) according to research presented today at ESC Congress 2020.
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke, according to the American Heart Association.
A major cross institutional research collaboration aimed at reducing the number of patients harmed in Australia has received $8.4 million in funding in the latest round of National Health and Medical Research Council (NHMRC) program grants.
› Verified 6 days ago
Colleton Medical Center Acute Care Hospital Location: 501 Robertson Boulevard, Walterboro, South Carolina 29488 Phone: (843) 782-2000 |